Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in the company. The WSJ reports that the large drug giant has approached what was the #5 biotech on NASDAQ by market cap, now #4, about an acquisition. This is all informal as of now, but when one [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Posts Tagged biotech
If there is one single stock sector which could be immune to the crummy jobs data so far this week, it is biotech. Just don’t look at Dendreon Corporation (NASDAQ: DNDN) for much warmth today. There is not any new negative news on PROVENGE itself accounting for the big drop. Dendreon’s drop today is over [[ This is a content summary only.
The Baltic Dry Index, which tracks global shipping rates, has fallen for 24 consecutive days, its longest losing streak since August 2005. The BDI closed at 2,406 yesterday, its lowest point since last October. As shipping rates fall, dry bulk shippers like Dryships Inc.
Earnings season has taken out some of the sting from biotech and biohealth trading reactions. Today’s version of the BioHealth Business Daily is showing news and moves seen in Charles River Laboratories International, Inc. (NYSE: CRL), Dendreon Corporation (NASDAQ: DNDN), NexMed, Inc. (NASDAQ: NEXM), Radient Pharmaceuticals Corporation (AMEX: RPC), Teva Pharmaceutical Industries Limited (NASDAQ: TEVA), [[ This is a content summary only
Today’s version of the BioHealth Business Daily seems to be more influenced by outside factors more than big blockbuster news. Still we have many movers, some on news. Today’s cast members are Adeona Pharmaceuticals, Inc. (AMEX: AEN), ArQule Inc
Today was a crazy day for the markets, and as you’d expect there were many movers in the drug and biotech sectors. Today’s edition of the BioHealth Business Daily covers ARCA biopharma, Inc. (NASDAQ: ABIO), Genzyme Corporation (NASDAQ: GENZ), Somaxon Pharmaceuticals, Inc.
Monday is seeing many winners and losers in the healthcare sector on the heels of the healthcare reform passage in the House of Representatives this weekend. We are focusing solely on the biotech, drug and BioHealth space where actual news is driving the shares mentioned. We are seeing key moves today in Cell Therapeutics, Inc
The Unusual Suspects (AMLN, LLY, ALKS, ESLR, ENER, DPS, ATHN, SQNM, ABK, NKE, FDX, GME, COMS, PALM)
Mar 14
This week we have several issues to watch. Earnings season is mostly done but there are still many on deck in this week’s unusual suspects. Amylin Pharmaceuticals, Inc.
Biotech firm XenoPort (XNPT) will lay-off half of its employees. The company lists 219 full-time workers.
